Sung Junsik J, Shaw Jacob R, Rezende Josie D, Dharmaraj Shruti, Cottingham Andrea L, Weldemariam Mehari M, Jones Jace W, Kane Maureen A, Pearson Ryan M
bioRxiv. 2024 Nov 18:2024.11.13.623417. doi: 10.1101/2024.11.13.623417.
Plant-derived nanoparticles (PDNP) are nano-sized particles isolated from various edible plants that contain bioactive components involved in regulating cellular immune responses against pathogenic intrusion and inflammation.
This study describes a novel PDNP derived from Walp (maca) that efficiently captures pro-inflammatory cytokines and acute phase proteins in its protein corona to enhance survival in two representative lethal models of sepsis.
Lipid nanoparticles were isolated from maca (MDNP) and triacylglycerols and phytoceramides were identified as major constituents using lipidomics. The physicochemical properties of MDNPs were determined, anti-inflammatory effects of MDNP were evaluated using models and using endotoxemia and cecal ligation and puncture (CLP) polymicrobial sepsis models. Proteomic analysis of MDNP in healthy or LPS-induced inflammatory plasma was used to determine the composition and inflammatory pathways modulated due to the MDNP protein corona.
studies showed that MDNP were non-toxic, reduced macrophage activation, and effectively sequestered pro-inflammatory cytokines to mitigate NF- B activity under lipopolysaccharide (LPS) stimulation. In a pre-established LPS-induced endotoxemia model, MDNP-treated mice showed significantly reduced systemic pro-inflammatory cytokines and enhanced survival. Untargeted proteomics and pathway analysis of the MDNP protein corona identified an enrichment in acute phase proteins in MDNP-LPS plasma coronas. MDNP treatment also significantly improved survival in the CLP sepsis model in the absence of antibiotics.
This work identified MDNP as an efficient, plant-derived lipid NP that broadly sequesters and neutralizes a compilation of inflammatory mediators in their coronas, offering multimodal therapeutic potential for treating inflammatory diseases.
植物源纳米颗粒(PDNP)是从各种可食用植物中分离出的纳米级颗粒,其含有参与调节针对病原体入侵和炎症的细胞免疫反应的生物活性成分。
本研究描述了一种源自秘鲁人参(玛卡)的新型植物源纳米颗粒,其能在其蛋白冠层中有效捕获促炎细胞因子和急性期蛋白,以提高在两种代表性脓毒症致死模型中的存活率。
从玛卡中分离出脂质纳米颗粒(MDNP),并使用脂质组学鉴定三酰甘油和植物神经酰胺为主要成分。测定了MDNP的物理化学性质,使用细胞模型评估了MDNP的抗炎作用,并使用内毒素血症和盲肠结扎穿刺(CLP)多微生物脓毒症模型进行评估。对健康或脂多糖(LPS)诱导的炎症血浆中的MDNP进行蛋白质组学分析,以确定由于MDNP蛋白冠层而调节的组成和炎症途径。
研究表明,MDNP无毒,可减少巨噬细胞活化,并在脂多糖(LPS)刺激下有效隔离促炎细胞因子以减轻核因子-κB活性。在预先建立的LPS诱导的内毒素血症模型中,经MDNP处理的小鼠全身促炎细胞因子显著减少,存活率提高。对MDNP蛋白冠层的非靶向蛋白质组学和途径分析确定,MDNP-LPS血浆冠层中的急性期蛋白富集。在没有抗生素的情况下,MDNP治疗也显著提高了CLP脓毒症模型中的存活率。
这项工作确定MDNP是一种高效的植物源脂质纳米颗粒,可在其冠层中广泛隔离和中和一系列炎症介质,为治疗炎症性疾病提供多模式治疗潜力。